Thermo Fisher Scientific Inc. (NYSE:TMO) acquired PeproTech, Inc. for $1.85 billion on December 30, 2021. Total cash purchase price of approximately $1.9 billion. PeproTech will become part of the biosciences business within Thermo Fisher and will be integrated into the Life Sciences Solutions Segment. Joe Basile, Adrienne Ellman, Jonathan Book, Corey Brown, Tom Draper, Joshua Jarvis, Jonathan Keselenko, Teresa Martland, Earl Mellott, Lu Racco, Anne Seymour, and Lucas Watkins of Foley Hoag LLP acted as legal advisor to Thermo Fisher Scientific Inc. JPMorgan Chase & Co. (NYSE:JPM) acted as financial advisor to PeproTech, Inc. in the transaction.

Thermo Fisher Scientific Inc. (NYSE:TMO) completed the acquisition of PeproTech, Inc. on December 30, 2021. Under the terms of agreement, consideration paid is along with cash acquired of $83 million.